Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,756 people get AGN articles and Market Currents by email alert.
Get email alerts on AGN »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
Allergan: Earnings PreviewZacks Investment Research • Tue, May 1, 2012 -
-
Earnings Preview: AllerganTheflyonthewall • Wed, Feb 1, 2012 -
-
Allergan Beats, Revises GuidanceZacks Investment Research • Wed, Aug 3, 2011
-
-
-
-
-
Allergan: Too Late to Jump In?Derastone • Mon, Aug 9, 2010
-
Put Sellers Bet Allergan Will Hold FirmoptionMONSTER • Mon, Aug 2, 2010 -
Allergan Attracts Bearish PositionoptionMONSTER • Mon, May 3, 2010
-
Earnings Preview: AllerganTheflyonthewall • Thu, Apr 29, 2010
-
Allergan Gets FDA Approval: Botox Has a Medical Use?Ockham Research • Wed, Mar 10, 2010
To learn more about Seeking Alpha Pro, click here.
-
Allergan Management Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 30, 2012
-
Allergan Management Discusses Q3 2011 Results - Earnings Call TranscriptWed, Oct 26, 2011 • 2 Comments
-
Allergan's CEO Discusses Q1 2011 Results - Earnings Call TranscriptThu, May 5, 2011
-
Allergan's CEO Discusses Q4 2010 Results - Earnings Call TranscriptWed, Feb 2, 2011
-
Allergan CEO Discusses Q3 2010 Results - Earnings Call TranscriptMon, Nov 1, 2010
-
Allergan Q2 2010 Earnings Call TranscriptMon, Aug 2, 2010
-
Allergan Q1 2010 Earnings Call TranscriptFri, Apr 30, 2010
-
Allergan, Inc. Q4 2009 Earnings Call TranscriptThu, Feb 4, 2010
-
Allergan Q3 2009 Earnings Call TranscriptThu, Oct 29, 2009
-
Allergan Inc. Q2 2009 Earnings Call TranscriptFri, Jul 31, 2009
-
Allergan Inc. Q1 2009 Earnings Call TranscriptFri, May 1, 2009
-
Allergan Q4 2008 Earnings Call TranscriptWed, Feb 4, 2009
-
Allergan Inc. F3Q08 (Qtr End 9/30/08) Earnings Call TranscriptWed, Oct 29, 2008
-
at CNBC.com (May 2, 2013)
-
at CNBC.com (May 1, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
Business Wire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
Business Wire (Apr 30, 2013)
-
at CNBC.com (Apr 26, 2013)
-
Business Wire (Apr 3, 2013)
-
at CNBC.com (Mar 26, 2013)
-
Business Wire (Feb 20, 2013)
-
at CNBC.com (Feb 6, 2013)
-
at CNBC.com (Feb 5, 2013)
-
at MarketWatch.com (Feb 5, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Jan 31, 2013)
-
at Fox Business (Jan 23, 2013)
AGN vs. ETF Alternatives
Company Description
We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely and express themselves more fully. Our diversified... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Wednesday, May 1, 12:50 PM
Midday top 10 gainers: IQNT +60%. BCOV +31%. CNIT +28%. MNOV +21%. MSPD +19%. SONS +15%. TRLA +15%. RATE +15%. REGN +14%. SGI +14%.
Midday top 10 losers: ACCL -21%. RBC -20%. ESBF -17%. LEDS -16%. KFRC -15%. AGN -14%. CRAY -13%. ASTX -13%. XXIA -13%. UTI -12%. Comment! [On the Move] - Wednesday, May 1, 11:23 AM Allergan (AGN -9.4%) dives as management - on today's earnings call - has less than great progress to report on a couple of drugs in development. Regeneron (REGN +12.4%) spikes higher. 1 Comment [Healthcare, Breaking News, On the Move]
- Wednesday, May 1, 9:23 AM More on Allergan's (AGN) Q1: Modest beats on the top and bottom line as product sales in specialty pharmaceuticals and medical devices increase 8.1% and 10.2% respectively. The company says it sees total product sales of $5.98-6.2B for FY13 and $1.5-1.575B for Q2 (consensus is towards the high end of both ranges at $6.16B for the full year and $1.57B for Q2). Non-GAAP EPS should come in at $4.70-4.76 for FY13 and $1.18-1.20 for Q2 against analysts' estimates of $4.76 and $1.22. Shares -3% premarket. (PR) Comment! [Healthcare, Earnings, On the Move]
- Wednesday, August 1, 2012, 9:50 AM More on Allergan (AGN +7.9%) Q2: net profit rises to $296M from $249M. Sales breakdown: specialty pharmaceuticals +5% and 8.8% on a constant currency basis; medical devices +4% and +8.3%. Guidance: FY EPS $4.15-$4.19 vs. consensus of $4.17, revenue of $4.74B-$4.85B vs. $5.85B. Q3: EPS of $1.02-$1.04 vs. $1.06, revenue of $1.37B-$1.445B vs. $1.44B. Comment! [Earnings, Healthcare, On the Move]
- Wednesday, August 1, 2012, 9:20 AM Allergan (AGN): Q2 EPS of $1.07 beats by $0.01. Revenue of $1.47B (+6.5% Y/Y) misses by $30M. Shares +2.3% premarket. (PR) Comment! [Earnings, Healthcare, On the Move]
- Thursday, May 3, 2012, 1:26 PM Allergan (AGN +1.5%) continues to battle back from yesterdays's 6% selloff after missing Q1 estimates, helped by positive comments out of Susquehanna this morning. The firm says AGN posted a good quarter, but wasn't surprised by the selloff and believe it's been overdone. Susquehanna says AGN adequately explained its shortcomings and expects to see growth accelerate through the remainder of the year. Worth noting: Jefferies says valuation is still rich on a relative basis, trading at around 20x estimates, versus its peers at 12x. Comment! [Healthcare, On the Move]
- Wednesday, May 2, 2012, 9:12 AM Allergan (AGN): Q1 EPS of $0.86 misses by $0.01. Revenue of $1.37B (+9.5% Y/Y) in-line. Shares -2.5% premarket. (PR) Comment! [Earnings, Healthcare, On the Move]
- Monday, February 13, 2012, 1:54 PM Obagi Medical (OMPI +3.6%) trades higher on positive comments out of Cantor this morning. The firm says that recent data points from Allergan (AGN +1%) and Estee Lauder (EL -1.4%) support its view that the skin care products manufacturer will beat Q4 EPS estimates. Comment! [Healthcare, On the Move, Quick Ideas]
- Thursday, February 2, 2012, 9:04 AM Allergan (AGN): Q4 EPS of $1.00 in-line. Revenue of $1.38B (+7.2% Y/Y) misses by $30M. Shares -1.7% premarket. (PR) Comment! [Earnings, On the Move, Healthcare]
- Thursday, December 1, 2011, 2:04 PM Allergan (AGN +0.8%) gets a boost from an upgrade to Buy at Argus on valuation, citing its strong growth prospects. Comment! [Healthcare, On the Move]
- Wednesday, October 26, 2011, 12:13 PM Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical sales, but the company's issues cautious Q4 guidance below Street estimates. It now forecasts current-quarter earnings of between $0.97 - $0.99 per share on sales of $1.33B to $1.41B, below analysts expectations for an EPS of $1.01 on revenue of $1.41B. Comment! [On the Move, Healthcare]
- Wednesday, October 26, 2011, 9:06 AM Allergan (AGN): Q3 EPS of $0.92 beats by $0.02. Revenue of $1.33B in-line. Sees Q4 EPS of $0.97-0.99 vs $1.01 consensus. Shares -2.2% premarket. (PR) Comment! [On the Move, Healthcare, Earnings, Breaking News]
- Wednesday, August 24, 2011, 3:06 PM More on Allergan (AGN +2.4%): Shares started trading higher yesterday in advance of today's announcement the firm's BOTOX solution was approved by the FDA. Comment! [Healthcare, On the Move]
- Wednesday, August 24, 2011, 1:02 PM Allergan (AGN +2.5%) shares jump following news that the FDA approves Botox to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder. Comment! [Healthcare, On the Move]
- Tuesday, August 16, 2011, 12:59 PM Allergan (AGN +1.3%) trades higher on a CS First Boston valuation upgrade. The firm says an improving R&D pipeline and strong postioning of its glaucoma products to compete with generic alternatives should spur margin growth in H2. Comment! [Healthcare, On the Move]
-
- View all 0 replies
-
- View all 0 replies
-
speculatacular
$AGN FDA has voted unanimously that the benefits of Allergan's JUVÉDERM VOLUMA outweigh the risks. http://bit.ly/10w18Yz - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Red Acre Investments
just published part 1 of our April Biotech binary event watch : http://bit.ly/ZmquIg $AGN, $THRX, $ENDP, $SCMP, $GILD - View all 0 replies
-
O. Young Kwon
TANER Stock Model (TSM) Momentum 4/2/2013 (Tuesday): (1-2) Allergan ($AGN) Yum Brands ($YUM) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 0 replies
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
LATEST REPLIES
-
O. Young Kwon
TANER Stock Model (TSM) Momentum 4/2/2013 (Tuesday): (1-2) Allergan ($AGN) Yum Brands ($YUM) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 11/5/2012 (Monday): (2-3) <FLS BEN AGN> Flowserve (FLS) <c> - View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 10/19/2012 (Friday): (1-2) Allergan (AGN) Mosaic (MOS) Nu Skin (NUS) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 5 replies
-
-
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in THE TANER DATA (my Instablog) with their security names. yk
-
- View all 3 replies
-
O. Young Kwon: article: Link:http://seekingalpha.com/a/hitr The TANER System synthesizes performances and relative strengths thoroughly <c>
-
O. Young Kwon: The letters in the parentheses are ticker symbols which are in the Daily TANER Momentum [DTM] (my Instablog) with their security names. yk